Viral infections and drug hypersensitivity

Area of Science:

• Immunology
• Virology
• Dermatology

Background:

• Virus infections and T-cell-mediated drug hypersensitivity reactions (DHR) exhibit complex interactions.
• Systemic viral infections often precede DHR, influencing drug responses through immune priming.
• The sequence can be reversed, with severe DHR preceding viral reactivation, as seen in DRESS syndrome.

Purpose of the Study:

• To elucidate the mechanisms by which viral infections influence T-cell-mediated drug hypersensitivity reactions.
• To explain the reversed sequence observed in DRESS syndrome where DHR precedes viral reactivation.
• To understand the transient nature of DHR during viral infections and asymptomatic viremia post-DRESS.

Main Methods:

• The study proposes mechanisms involving virus-induced co-stimulation and enhanced pharmacological interactions (p-i) of drugs with immune receptors.
• It explores how viral infections create an immune-stimulatory environment favoring drug-specific T-cell activation.
• The paper hypothesizes that massive p-i stimulation in DRESS activates latent herpes viruses.

Main Results:

• Viral infections prime T-cells to drugs via enhanced co-stimulation or increased drug-receptor interactions (p-i).
• This leads to drug-specific immune reactions, manifesting as exanthema or other DHR.
• DRESS syndrome can cause T-cell activation, leading to cytotoxic activity against herpes peptide-expressing cells and subsequent viral release.

Conclusions:

• Viral infections significantly modulate T-cell responses to drugs, increasing DHR risk.
• DRESS syndrome can paradoxically trigger viral reactivation through potent p-i immune stimulation.
• These interactions explain transient DHR during infections and post-DRESS viremia patterns.